TrialJournal of diabetes research2021

Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial.

Lu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.